Livedoid and Purpuric Skin Eruptions Associated With Coagulopathy in Severe COVID-19
Caren Droesch, Mytrang Hoang, Maria T. DeSancho, Eun-Ju Lee, Cynthia M. Magro, Joanna Harp
Abstract
Between 2012 and 2017, overall Medicare reimbursements for PDT services in metropolitan regions increased by $1 601 015 (average annual growth rate [AAGR], 4.0%), with 19 219 (AAGR, 4.7%) additional claims; overall Medicare reimbursements for PDT services in nonmetropolitan regions increased by $122 076 (AAGR, 3.2%), with 1625 (AAGR, 3.9%) additional claims (Table As of 2017, metropolitan counties accounted for 90.9% of Medicare reimbursements for PDT claims ($9 260 322 of $10 184 822).
Topics & Concepts
MedicineBullous pemphigoidLinagliptinInternal medicineHazard ratioIncidence (geometry)Propensity score matchingDiabetes mellitusPemphigoidSulfonylureaType 2 diabetesConfidence intervalImmunologyEndocrinologyInsulinOpticsAntibodyPhysicsAutoimmune Bullous Skin DiseasesPlatelet Disorders and TreatmentsDiabetes Treatment and Management